NCT05266417View on ClinicalTrials.gov

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

December 1, 2026

Study Completion Date

January 30, 2027

Conditions
Parkinson Disease
Interventions
DRUG

INS-GSH

Intranasal INS-GSH Twice Daily

DRUG

Matched Placebos

Intranasal Matched Placebos Twice Daily

Trial Locations (2)

33012

RECRUITING

Las Mercedes Medical Research, Hialeah

33314

RECRUITING

Institute for Neuroimmune Medicine, Davie

Sponsors
All Listed Sponsors
lead

Gateway Institute for Brain Research

INDUSTRY